SCHEMBL3172350

SCHEMBL3172350

CC(=O)NCCNc1cc(NC(=O)CN2CCN(c3ccccn3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRB P10828 1/20 0.55
▸ NPSR1 Q6W5P4 1/20 0.55
▸ ALDH1A1 P00352 7/20 0.52
▸ TSHR P16473 2/20 0.52
▸ LMNA P02545 2/20 0.52
▸ DRD2 P14416 4/20 0.52
▸ DRD4 P21917 4/20 0.52
▸ DRD3 P35462 3/20 0.52
▸ MAPT P10636 3/20 0.51
▸ SMN1; SMN2 Q16637 3/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ CYP3A4 P08684 1/20 0.51
▸ CYP2C9 P11712 1/20 0.51
▸ CYP2C19 P33261 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ KMT2A Q03164 6/20 0.50
▸ MEN1 O00255 5/20 0.50
▸ KDM4E B2RXH2 1/20 0.49
▸ GAA P10253 1/20 0.49
▸ ATM Q13315 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3160939 0.92 ALDH1A1 (0.52) THRBNPSR1ALDH1A1TSHRLMNA
SCHEMBL3172939 0.91 DRD2 (0.44) THRBNPSR1ALDH1A1TSHRLMNA
SCHEMBL3162425 0.88 EGFR (0.53) ALDH1A1TSHRLMNAMAPTSMN1; SMN2
SCHEMBL3162096 0.88 OGA (0.45) NPSR1ALDH1A1TSHRDRD4MAPT
SCHEMBL3171920 0.86 ADORA1 (0.47) ALDH1A1KDM4EATM
SCHEMBL3174496 0.86 ALDH1A1 (0.45) ALDH1A1TSHRLMNAMAPTCYP3A4
SCHEMBL13920222 0.86 OGA (0.43) NPSR1ALDH1A1TSHRDRD4MAPT
SCHEMBL3163144 0.86 ADORA3 (0.46) ALDH1A1TSHRLMNAMAPTSMN1; SMN2
SCHEMBL3163125 0.85 NPC1 (0.47) NPSR1ALDH1A1MAPTKMT2AMEN1
SCHEMBL3164709 0.85 NPC1 (0.47) NPSR1ALDH1A1MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback